Well well well.. here we have another Pinto-Mariz paper analysing CD49d in DMD and Idiopathic Inflammatory Myositis, the 2 diseases CSL has been giving out research grants for..
So ANP has had 1 former CSL executive replace another former CSL executive as Chairman.. If CSL does not get involved with ANP and its future potential revenue it would be like allowing the Chinese to buy Rio Tinto. Thankfully the government did not allow this to happen back in 2009.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531250/
Another Pinto-Mariz paper
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |